GLP-1 SM 20mg Peptides
Engineered for serious research, this lyophilized peptide is produced to deliver reliable performance and consistent results.
This GLP-1 SM lyophilized peptide vial provides a clean, stable format for laboratory workflows, featuring a total content of 20mg per single vial. Prepared for precise handling and controlled study design, it supports rigorous investigative use across method development, signaling studies, and other non-clinical applications.
- Each vial contains 20mg of GLP-1 SM, prepared for controlled laboratory evaluation of GLP-1 pathway mechanisms, receptor interactions, and related assay development.
As a non-edible research material, this vial is designed for reconstitution according to laboratory protocol, enabling accurate solution preparation and consistent aliquoting. The lyophilized format helps preserve structural integrity and facilitates streamlined storage, handling, and transport under appropriate laboratory conditions. Researchers can expect a clean, low-residue profile that supports repeatable assay performance and dependable comparative analysis across runs.
Every lot is produced in the USA with disciplined process controls, careful environmental monitoring, and documentation to support traceability. Batches are evaluated by independent laboratories to confirm identity and purity, with analytical testing (e.g., HPLC and MS) guiding release. Each unit is lot-coded and sealed to maintain chain-of-custody integrity from our facility to your lab. A certificate of analysis is available by lot number to support method validation and quality review.
Peptide Scientific Labs prioritizes careful material stewardship at every step—sourcing, handling, and packaging are performed to protect peptide quality and consistency. This product is intended solely for laboratory research use, not for human or veterinary applications, therapeutic use, or household use. Store and handle in alignment with established peptide best practices; protect from moisture and excessive heat, and avoid repeated freeze-thaw cycles once reconstituted. Follow your facilitys protocols for reconstitution, aliquoting, and disposal.
Choose GLP-1 SM 20mg lyophilized peptide when your work demands clarity, consistency, and confidence—supported by transparent testing, disciplined process control, and the reliability of a USA-based research supplier.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is GLP-1 SM?
GLP-1 SM appears to be a supplier-specific GLP-1-based research product. The 'SM' label is not a standardized pharmacologic name, so a careful description should avoid guessing the exact analog unless the sequence or active ingredient is shown on the specification sheet. It is best framed as a GLP-1-pathway research compound for laboratory use only.
What is GLP-1 SM typically studied for?
GLP-1-based compounds are generally studied for appetite regulation, glucose handling, insulin-related signaling, and body-weight change in metabolic models. For this specific item, the strongest FAQ wording is to explain the GLP-1 research category while also telling users to confirm the exact analog on the lot documents.
What are GLP peptides?
GLP peptides — glucagon-like peptides — are a family of peptides derived from the post-translational processing of the proglucagon precursor. The main members are GLP-1 and GLP-2, both of which are produced primarily by intestinal L-cells. GLP-1 is studied in the context of insulin secretion, glucose metabolism, and appetite signaling, while GLP-2 is investigated for its role in intestinal epithelial biology.
A number of synthetic analogs and research compounds exist in this category, including semaglutide-class and tirzepatide-class sequences, as well as dual- and triple-agonist research peptides. All GLP peptide products from Peptide Scientific Labs are lyophilized research materials intended solely for in vitro laboratory investigation.
How do GLP analogs differ from native GLP hormones?
Native GLP-1 has a very short half-life in plasma — on the order of a few minutes — because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). GLP analogs are engineered peptides that modify the native sequence or attach additional groups such as fatty acid chains, in order to resist DPP-4 degradation, extend half-life, and optimize receptor binding.
This extended stability is what makes GLP analogs useful in research as practical tools for studying the GLP-1 and related receptor systems in controlled experiments. The analogs differ from native GLP hormones primarily in their pharmacokinetic profile and, in some cases, their receptor selectivity across the GLP-1, GIP, and glucagon receptor families.
What is the difference between GLP-1, GLP-2, and GLP-3 in research?
GLP-1 and GLP-2 are both produced from the proglucagon precursor. GLP-1 is studied in connection with the GLP-1 receptor, insulin secretion, and appetite signaling, while GLP-2 is studied primarily in connection with the GLP-2 receptor and intestinal epithelial biology. The two peptides share a common precursor but have different receptor targets and research focuses.
GLP-3 is not a classical endogenous peptide in the same way as GLP-1 and GLP-2. The term is sometimes used as a research label for engineered or triple-agonist peptides that combine activity at GLP-1, GIP, and glucagon receptors in a single molecule. In this sense, GLP-3 in research usually refers to a designed multi-target compound rather than a naturally occurring hormone.